(Adds legal comment in paragraph 13) * Novo accuses Lilly of claiming its weight-loss medicines outperform Novo's * Danish drugmaker alleges Lilly violated ad and unfair competition laws in Zepbound
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)